Pay in 4 interest-free payments of $30.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Anastassov V
Iberdomide (CC-220) is currently in phase 2 clinical trials for the treatment of systematic lupus erythematosus (SLE) and phase 1b/2a clinical trials for relapsed and refractory multiple myeloma (MM)
nude mice) treatment potently inhibits hemangioma growth in mice
It blocks the action of DNA polymerases
and selective OX2R antagonist (pKi values of 8
SARS-CoV MPro-IN-1 28007 Anastassov VSARS CoV MPro IN 1 is a SARS CoV 2 3CLpro covalent inhibitor, with an IC50 of 40 nM. SARS CoV MPro IN 1 shows good anti SARS CoV 2 infection activity in cell culture with an EC50 of 0. 33 M. Product information CAS Number: 2413716 71 7 Molecular Weight: 464. 49 Formula: C25H25FN4O4 Chemical Name: (2S) 3 (3 fluorophenyl) 2 [(1H indol 2 yl)formamido] N [(2S) 1 oxo 3 [(3S) 2 oxopyrrolidin 3 yl]propan 2 yl]propanamide Smiles:
US$ 40.00
US$ 2160.64
US$ 40.00
US$ 35.00
US$ 3858.70
US$ 35.00